BMW’s third-quarter pretax profit rose 9.6 percent to $2.87 billion, mainly due to rebounding Chinese demand for luxury cars.
The German automaker enjoyed a 9.8 percent increase in deliveries of its vehicles during the quarter, with the 31 percent spike in China offsetting a 15.7 percent drop in the US.
The company expects to achieve an EBIT (earnings before interest and tax) margin of between 0 percent and 3 percent for the automotive segment in 2020.
The automotive EBIT margin rebounded to 6.7 percent from minus 10.4 percent in the second quarter and 6.6 percent last year, despite a 50 percent surge jump in sales of lower-margin electric and hybrid cars.
However, BMW expects overall deliveries of high-end vehicles and group pretax profit to be significantly lower than last year due to the high level of risk of the pandemic, which is regaining momentum.


X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns 



